IDBS Named Top-Tier Software Vendor by APPS RUN THE WORLD in the APPS and CLOUD TOP 500 Market Report

IDBS Strengths, Domain Expertise, and Key Differentiators

IDBS is a global provider of cutting-edge enterprise data management, analytics, and modeling solutions. Employed by over 200 pharmaceutical firms, prominent healthcare institutions, academic research institutions, and high-tech enterprises, the company's advanced platform technologies are instrumental in enhancing efficiency, lowering costs, and augmenting productivity in both industrial R&D and clinical research endeavors.

IDBS's solutions empower scientists, healthcare institutions, and research and development enterprises to expedite the creation of cutting-edge therapeutics, diagnostics, and personalized treatments. Additionally, they facilitate advancements in cleaner engines and fuels, breakthroughs in agricultural productivity, the production of healthy and safer food items, as well as the development of high-tech materials and consumer goods.

IDBS Recent Developments

In October 2021, IDBS revealed its membership in BioPhorum, a platform facilitating collaboration among biopharmaceutical manufacturers and suppliers to tackle industry challenges collectively. IDBS specifically joined the Information Technology Phorum (BPIT), allowing access to workstreams and teams addressing crucial industry topics like QC lab evolution, cybersecurity, predictive analytics, and IT for cell and gene therapy.

In March 2021, IDBS introduced Polar BioAnalysis, an extension of the Polar BioPharma Lifecycle Management (BPLM) Platform, aimed at incorporating industry best practices in preclinical drug qualification. Polar BioAnalysis enhances the functionalities of IDBS Polar, a cloud-based platform tailored to address workflow, quality, and data analysis complexities throughout the development lifecycle. By amalgamating the Polar platform with pre-configured workflows grounded in over 25 years of industry expertise, Polar BioAnalysis empowers organizations to enhance quality assurance and reproducibility, streamline study cycles, and expedite time-to-market.

In December 2019, IDBS extended its operations in India to leverage the burgeoning opportunities in research and development strategically. This expansion was prompted by escalating demand and an expanding regional clientele. To efficiently oversee IDBS's market footprint in India, the company appointed Manish Manakchand as Commercial Director and Braj Thakur as National Sales Manager.

IDBS Mergers and Acquisitions (M&A) Activities

In November 2021, IDBS revealed its acquisition of Skyland Analytics, marking a milestone in the creation of the inaugural BioPharma Lifecycle Management (BPLM) solution supporting therapies from early development to commercial manufacturing. Renowned for its Skyland PIMS software, Skyland Analytics seamlessly integrates product, process, and patient data across the biopharma lifecycle and supply chain, expediting process comprehension and ensuring product quality. With over half of biopharma organizations facing challenges due to data fragmentation, Skyland PIMS stands out for its ability to manage and contextualize data throughout both clinical and commercial production phases, significantly accelerating insights. Skyland Analytics' products will maintain their current branding as Skyland PIMS in the immediate term, with the company being swiftly integrated into IDBS.

In October 2017, the Danaher Corporation completed its acquisition of IDBS. This integration saw IDBS becoming part of Danaher's esteemed Life Sciences platform, alongside notable entities like SCIEX, Phenomenex, Beckman Coulter Life Sciences, Pall, Leica Microsystems, and Molecular Devices. Positioned within this platform, IDBS serves as a cornerstone, offering a range of life sciences informatics and knowledge management solutions. These solutions are designed to significantly enhance the efficiency of discovering, developing, and manufacturing new drugs and therapies.

IDBS Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying IDBS applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of IDBS and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified IDBS E-WorkBook Cloud, customers.

IDBS Key Enterprise and Cloud Applications

IDBS E-WorkBook Cloud,

IDBS Revenues, $M:

IDBS Revenue Breakdown By Type, $M:

IDBS Enterprise Applications Revenues By Functional Markets, $M:

IDBS Enterprise Applications Revenues By Verticals, $M:

IDBS Revenues By Region, $M

IDBS Direct vs Indirect sales

IDBS Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified IDBS Customers

No. of IDBS Customers: 210

No. of IDBS Enterprise Applications Customers: 210

No. of IDBS Cloud Customers: x

No. of IDBS Cloud Subscribers: x

IDBS products are currently utilized by more than 50,000 researchers spanning 25 countries. Their clientele comprises 22 out of the top 25 global pharmaceutical firms, along with various other research and development-driven entities in sectors such as biotechnology, agricultural sciences, chemicals, consumer goods, energy, food and beverage, and healthcare.

IDBS Market Opportunities, M&A and Geo Expansions

In August 2021, IDBS expanded its analytics capabilities through a strategic partnership with Tableau. This collaboration involves integrating Tableau's visual and analytics features into IDBS's product suite, enhancing the visualization and utilization of scientific data managed by IDBS products. The partnership aims to provide customers with an integrated, interactive, and visual experience, facilitating the adoption of advanced analytics applications offered by IDBS. Together, the companies will promote awareness and showcase the benefits of their collaboration to a broad customer base. With this partnership, IDBS customers will gain access to advanced visual analytics and insights, thanks to Tableau's user-friendly interface, marking a significant advancement in data democratization and self-service analytics.

In November 2018, IDBS revealed the appointments of Graeme Dennis as Pre-Clinical Pharma Commercial Director, Abhay Kini as Director of Product Management, and April Pisek as Solutions Consultant. These strategic additions bolster IDBS's capacity to spearhead the transformation of R&D facilities into future-ready laboratories, while also reinforcing its preclinical presence in the scientific informatics arena. This move further solidifies IDBS's position as a premier global provider of data management solutions and services to preclinical and bioanalytical institutions.

IDBS aims to broaden its footprint in the Cloud through EWorkBook, an enterprise-grade web-based platform designed to facilitate seamless collaboration and data sharing among researchers. This product operates on Connect, a secure portal tailored for collaborating with external partners, and Inventory, which simplifies the management of samples, materials, and equipment.

IDBS Risks and Challenges

Functioning as a subsidiary, their operational strategy is contingent upon that of the parent company.

IDBS Ecosystem, Partners, Resellers and SI

In January 2024, IDBS announced a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) to leverage its Polar platform for digitizing data management and enhancing collaboration across the company's global R&D teams. This collaboration enables PIRC, PharmaEssentia's U.S. R&D hub, to electronically collaborate with its team in Taipei, Taiwan, replacing traditional paper-based experimental data recording methods.

In December 2021, IDBS and Synthace forged a strategic partnership to enhance IDBS Polar's capabilities in high-throughput process development (HTPD). Synthace's cloud-based automation platform complements Polar by automating data capture, structuring, and enrichment across bioreactors and analytical instruments. This collaboration empowers bioprocess development teams to adopt faster throughput approaches, facilitating better decision-making through reliable data sets, robust analysis, and modern data management. The combined solution enables users to confidently scale up to hundreds of automated experiments per month.

In April 2021, TetraScience and IDBS announced a strategic collaboration aimed at integrating the IDBS E-WorkBookTM and Tetra Data Platform into a unified ecosystem, facilitating comprehensive R&D data automation. This partnership is designed to deliver seamless connectivity between instrumentation and informatics solutions within life sciences R&D, enabling automatic collection, centralization, and harmonization of data in the Cloud. Users benefit from bidirectional instrument control, which streamlines workflows and enhances laboratory connectivity.

IDBS primarily conducts direct sales. Its technology partners encompass a range of companies such as ACD/Labs, ChemAxon, Microsoft, Oracle, Titian, Zifo RnD Solutions, a-tune, ITOCHU Techno-Solutions Corporation, and various others.

IDBS Cloud Infrastructure Insights

Subscribe to read more about:

• IDBS Public Cloud and Infrastructure (IaaS)
• IDBS Platform (PaaS)
• IDBS Application Delivery
• IDBS Private Cloud and Data Centers

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: